$2
Prelude Therapeutics is a biotechnology business based in the US. Prelude Therapeutics shares (PRLD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.89 – a decrease of 10.85% over the previous week. Prelude Therapeutics employs 128 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Prelude Therapeutics Inc stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Prelude Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PRLD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Prelude Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Prelude Therapeutics stock price (NASDAQ: PRLD)
Use our graph to track the performance of PRLD stocks over time.Prelude Therapeutics shares at a glance
Latest market close | $1.89 |
---|---|
52-week range | $1.66 - $6.80 |
50-day moving average | $4.68 |
200-day moving average | $4.20 |
Wall St. target price | $5.80 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.77 |
Is it a good time to buy Prelude Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Prelude Therapeutics price performance over time
Historical closes compared with the close of $1.89 from 2024-10-03
1 week (2024-09-27) | -10.85% |
---|---|
1 month (2024-09-04) | -63.51% |
3 months (2024-07-03) | -47.79% |
6 months (2024-04-04) | -60.13% |
1 year (2023-10-04) | -29.74% |
---|---|
2 years (2022-10-04) | -73.49% |
3 years (2021-10-04) | 31.61 |
5 years (2019-09-30) | N/A |
Prelude Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -35.22% |
Return on equity TTM | -58.45% |
Profit margin | 0% |
Book value | $3.31 |
Market Capitalization | $113.9 million |
TTM: trailing 12 months
Prelude Therapeutics share price volatility
Over the last 12 months, Prelude Therapeutics's shares have ranged in value from as little as $1.66 up to $6.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Prelude Therapeutics's is 1.516. This would suggest that Prelude Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Prelude Therapeutics's beta into context you can compare it against those of similar companies.
- Kura Oncology (KURA.US): 0.84
- Inovio Pharmaceuticals (INO.US): 0.834
- EXACT Sciences Corporation (EXAS.US): 1.269
Prelude Therapeutics overview
Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical trial for the treatment of selected relapsed/refractory myeloid or B-cell malignancies; PRT2527, a cyclin-dependent kinase, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; PRT3645, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 1 clinical trial for the treatment of advanced and metastatic solid tumors; and PRT3879, a SMARCA2 selective protein degrader, which is in Phase 2/3 clinical trial for the treatment of advanced and metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware. .
Frequently asked questions
What percentage of Prelude Therapeutics is owned by insiders or institutions?Currently 9.065% of Prelude Therapeutics shares are held by insiders and 94.105% by institutions. How many people work for Prelude Therapeutics?
Latest data suggests 128 work at Prelude Therapeutics. When does the fiscal year end for Prelude Therapeutics?
Prelude Therapeutics's fiscal year ends in December. Where is Prelude Therapeutics based?
Prelude Therapeutics's address is: 175 Innovation Boulevard, Wilmington, DE, United States, 19805 What is Prelude Therapeutics's ISIN number?
Prelude Therapeutics's international securities identification number is: US74065P1012
More guides on Finder
-
Best Paper Trading Platforms to Practice Trading With Fake Money in 2024
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 Best Day Trading Platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 Best International Stock Brokers to Invest in Foreign Assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question